Hepatocyte-selective gene transfer by galactosylated protein/linear polyethyleneimine/plasmid DNA complexes in mice

Journal of Biomedical Nanotechnology

Volumn 3, Issue 3, 2007, Pages 277-284

  Hohokabe, Miyuki ^a   Higuchi, Yuriko ^a   Mukai, Hidefumi ^a   Kawakami, Shigeru ^a   Hashida, Mitsuru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Aggregation; Galactosylated carrier; Hepatocyte; Linear polyethyleneimine; Non viral vector

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTOR; BOVINE SERUM ALBUMIN; DRUG CARRIER; GALACTOSE; PLASMID DNA; POLYETHYLENEIMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN 3T3; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG FORMULATION; ERYTHROCYTE AGGREGATION; FEMALE; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; LIVER CELL; LUNG PARENCHYMA; MOUSE; NANOPHARMACEUTICS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PROTEIN EXPRESSION; PROTEIN TRANSPORT; ZETA POTENTIAL;

EID: 45849149669     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2007.034     Document Type: Article

References (34)

1. M. Hashida, S. Kawakami, and F. Yamashita, Lipid carrier systems for targeted drug and gene delivery. Chem. Pharm. Bull. 53, 871 ( 2005).
2. S. Kawakami, F. Yamashita, N. Nishida, J. Nakamura, and M. Hashida, Glycosylated cationic liposomes for cell-selective gene delivery. Crit. Rev. Ther. Drug Carrier Syst. 19, 171 (2002).
3. G. Y. Wu and C. H. Wu, Receptor-mediated gene delivery and expression in vivo. J. Biol. Chem. 263, 14621 (1988).
4. S. Kawakami, S. Fumoto, M. Nishikawa, F. Yamashita, and M. Hashida, In vivo gene delivery to the liver using novel galactosylated cationic liposomes. Pharm. Res. 17, 306 (2000).
5. M. A. Arangoa, N. Düjzgüneş, and C. Tros de Ilarduya, Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes. Gene Ther. 10, 5 ( 2003).
6. E. Perouzel, M. R. Jorgensen, M. Keller, and A. D. Miller, Synthesis and formulation of neoglycolipids for the functionalization of liposomes and lipoplexes. Bioconjug. Chem. 14, 884 (2003).
7. J. P. Yang and L. Huang, Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA. Gene Ther. 4, 950 (1997).
8. S. Li, W. C. Tseng, D. B. Stolz, S. P. Wu, S. C. Watkins, and L. Huang, Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: Implications for intravenous lipofection. Gene Ther. 6, 585 (1999).
9. S. Fumoto, S. Kawakami, K. Shigeta, Y. Higuchi, F. Yamashita, and M. Hashida, Interaction with blood components plays a crucial role in asialoglycoprotein receptor-mediated in vivo gene transfer by galactosylated lipoplex. J. Pharmacol. Exp. Ther. 315, 484 ( 2005).
10. S. Fumoto, S. Kawakami, Y. Ito, K. Shigeta, E. Yamashita, and M. Hashida, Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation. Mol. Ther. 10, 719 (2004).
11. A. Sato, M. Takagi, A. Shimamoto, S. Kawakami, and M. Hashida, Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice. Biomaterials 28, 1434 (2007).
12. K. Morimoto, M. Nishikawa, S. Kawakami, T. Nakano, Y. Hattori, S. Fumoto, F. Yamashita, and M. Hashida, Molecular weight-dependent gene transfection activity of unmodified and galactosylated polyethylenimine on hepatoma cells and mouse liver. Mol. Ther. 7, 254 (2003).
13. K. Itaka, A. Harada, Y. Yamasaki, K. Nakamura, H. Kawaguchi, and K. Kataoka, In situ single cell observation by fluorescence resonance energy transfer reveals fast intra-cytoplasmic delivery and easy release of plasmid DNA complexed with linear polyethylenimine. J. Gene Med. 6, 76 (2004).
14. A. Akinc, M. Thomas, A. M. Klibanov, and R. Langer, Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J. Gene Med. 7, 657 (2005).
15. S. Kawakami, Y. Ito, P. Charoensit, F. Yamashita, and M. Hashida, Evaluation of proinflammatory cytokine production induced by linear and branched polyethylenimine/plasmid DNA complexes in mice. J. Pharmacol. Exp. Ther. 317, 1382 (2006).
16. R. Kircheis, L. Wightman, A. Schreiber, B. Robitza, V. Rossler, M. Kursa, and E. Wagner, Polyethylenimine/DNA complexes shielded by transferring target gene expression to tumors after systemic application. Gene Ther. 8, 28 (2001).
17. L. Wightman, R. Kircheis, V. Rossler, S. Carotta, R. Ruzicka, M. Kursa, and E. Wagner, Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J. Gene Med. 3, 362 (2001).
18. D. Goula, N. Becker, G. F. Lemkine, P. Normandie, J. Rodrigues, S. Mantero, G. Levi, and B. A. Demeneix, Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes. Gene Ther. 7, 499 (2000).
19. S. M. Zou, P. Erbacher, J. S. Remy, and J. P. Behr, Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse. J. Gene Med. 2, 128 (2000).
20. D. R. Vera, K. A. Krohn, R. C. Stadalnik, P. O. Scheibe, Tc-99m-galactosyl-neoglycoalburnin: In vivo characterization of receptor-mediated binding to hepatocytes. Radiology 151, 191 ( 1984).
21. F. Leclercq, C. Dubertret, B. Pitard, D. Scherman, and J. Herscovici, Synthesis of glycosylated polyethylenimine, with reduced toxicity and high transfecting efficiency. Bioorg. Med. Chem. Lett. 10, 1233 (2000).
22. K. Sagara and S. W. Kim, A new synthesis of galactose-poly (ethylene glycol)-polyethylenimine for gene delivery to hepatocytes. J. Control. Release 79, 271 (2002).
23. E. M. Kim, H. J. Jeong, I. K. Park, C. S. Cho, H. B. Moon, D. Y. Yu, H. S. Bom, M. H. Sohn, and I. J. Oh, Asialoglycoprotein receptor targeted gene delivery using galactosylated polyethylenimine-graft-poly (ethylene glycol): In vitro and in vivo studies. J. Control. Release 108, 557 (2005).
24. T. Fujita, M. Nishikawa, C. Tamaki, Y. Takakura, M. Hashida, and H. Sezaki, Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives. J. Pharmacol. Exp. Ther. 263, 971 (1992).
25. Y. C. Lee, C. P. Stowell, and M. J. Krantz, 2-Imino-2-methoxyethyl 1-thioglycosides: New reagents for attaching sugars to proteins. Biochemistry 15, 3956 (1976).
26. Y. Hattori, S. Suzuki, S. Kawakami, F. Yamashita, and M. Hashida, The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route. J. Control. Release 108, 484 (2005).
27. E. Wisse, An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids. J. Ultrastruct. Res. 31, 125 ( 1970).
28. E. Wisse, R. B. De Zanger, K. Charels, P. Van Der Smissen, and R. S. McCuskey, The liver sieve: Considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology 5, 693 (1985).
29. Z. Gatmaitan, L. Varticovski, L. Ling, R. Mikkelsen, A. M. Steffan, and I. M. Arias, Studies on fenestral contraction in rat liver endothelial cells in culture. Am. J. Pathol. 148, 2027 (1996).
30. H. Faneca, S. Simões, and M. C. Pedroso de Lima, Association of albumin or protamine to lipoplexes: Enhancement of transfection and resistance to serum. J. Gene Med. 6, 681 (2004).
31. Y. Liu, L. C. Mounkes, H. D. Liggitt, C. S. Brown, I. Solodin, T. D. Heath, and R. J. Debs, Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nat. Biotechnol. 15, 167 (1997).
32. S. Li and L. Huang. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther. 4, 891 (1997).
33. F. Liu, L. M. Shollenberger, and L. Huang, Non-immunostimulatory nonviral vectors. FASEB J. 18, 1779 (2004).
34. Y. H. Kim, J. H. Park, M. Lee, Y. H. Kim, T. G. Park, and S. W. Kim, Polyethylenimine with acid-labile linkages as a biodegradable gene carrier. J. Control. Release 103, 209 (2005).